A new method of purifying fibrinogen with both biological and immunological activity from human plasma

Masahiro Okuda1, Yahiro Uemura, Noriyuki Tatsumi

  • 1Product Development Division, Sysmex Corporation, Nishi-ku, Kobe, Japan. m-okuda@irc-net.co.jp

Related Concept Videos